HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
OMER
Omeros Corporation
There isn't enough reported data to score OMER yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
OMER Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Unavailable |
OMER's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
OMER PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 1x | $1.76 | -90% |
| Fair | 5.3x | $9.22 | -49% |
| Forward | 5.5x | $17.99 | — |
| Expensive | 10x | $17.82 | -1% |
| Current | 10x | $17.99 | — |
Historical ranges are pointers, not guarantees.
OMER's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
OMER Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Returning to profit | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect OMER to return to profit, with revenue growing. However, they disagree widely on these estimates.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
OMER Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.25 | +88% |
| Q2 2026 | $1.73 | +$3.84 |
| Q1 2026 | $1.15 | +$3.80 |
| Q4 2025 | -$0.05 | +$2.65 |
| Q3 2025 | -$2.02 | +$0.28 |
| Q2 2025 | -$2.11 | +$0.23 |
| Q1 2025 | -$2.65 | -$0.69 |
| Q4 2024 | -$2.70 | -$0.83 |
| Q3 2024 | -$2.30 | -797% |
OMER has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the stronger quarterly revenue trend. Revenue is up 49% for HIMS versus up 35% for OMER.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
OMER Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2021 | $30M | +15% |
| Q2 2021 | $28.8M | +113% |
| Q1 2021 | $21.1M | -11% |
| Q4 2020 | $10.6M | -68% |
| Q3 2020 | $26.1M | -13% |
OMER's revenue is growing: $29M last quarter, up 35% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 0.3% | N/A |
| Q1 2026 | -176% | N/A |
| Q3 2021 | -61% | +37 points |
| Q2 2021 | -83% | +121 points |
| Q1 2021 | -145% | -45 points |
| Q4 2020 | -318% | -247 points |
| Q3 2020 | -97% | -60 points |
| Q2 2020 | -205% | N/A |
OMER has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over OMER on cash generation, producing positive trailing cash flow while its opponent burns cash.
OMER Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $4.1M | +$26.1M |
| Q1 2026 | -$14.5M | +$21.4M |
| Q4 2025 | -$39.8M | -$10.8M |
| Q3 2025 | -$18.5M | +$13.6M |
| Q2 2025 | -$22M | +$24.1M |
| Q1 2025 | -$35.9M | +$6M |
| Q4 2024 | -$29M | +$5.9M |
| Q3 2024 | -$32.1M | +$621K |
OMER has burned cash in almost every quarter: −$69M over the past year, against −$119M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over OMER on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
OMER Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -491K shares |
| 1 year | +53% | +31M shares |
| 3 years | +43% | +26.8M shares |
| 5 years | +44% | +27.3M shares |
| Available history | +82% | +40.3M shares |
OMER has 90M diluted shares, up 53% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $5.7M |
| Q1 2026 | $4.2M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
OMER spent $10M buying back its own shares over the past year, after none the year before.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
OMER Net Leverage
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
OMER Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.2 | Neutral |
| Stochastic | 62.7 | Neutral |
OMER's weekly RSI is 57 (neutral) and its Stochastic is 63 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
OMER PE vs Healthcare Sector
| Metric | OMER | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 85 | 29 | 56 pts above |
OMER is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
OMER Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.1 | 0.5% below |
| 20 week MA | $16.0 | 13% above |
| 50 week MA | $13.4 | 34% above |
| 100 week MA | $9.89 | 82% above |
| 200 week MA | $7.06 | 155% above |
OMER has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
OMER Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.0 | $14.9 | -0.7% |
| 2021 | $14.9 | $7.64 | -49% |
| 2022 | $7.64 | $2.54 | -67% |
| 2023 | $2.54 | $3.27 | +29% |
| 2024 | $3.27 | $11.7 | +257% |
| 2025 | $11.7 | $15.7 | +35% |
| 2026 YTD | $15.7 | $18.0 | +15% |
OMER has the edge over HIMS on returns for 2026, with the stronger performance.